Citations (15)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Christine M. Litwin & Steven R. Binder. (2016) ANA testing in the presence of acute and chronic infections. Journal of Immunoassay and Immunochemistry 37:5, pages 439-452.
Read now
Read now
Y Muro, K Sugiura, Y Morita & Y Tomita. (2009) Evaluation of anti-ribosomal P protein immunoassay in Japanese patients with connective tissue diseases: comparison with an indirect immunofluorescence assay. Scandinavian Journal of Rheumatology 38:6, pages 460-463.
Read now
Read now
Articles from other publishers (13)
April Barnado, Ryan P. Moore, Henry J. Domenico, Sarah Green, Alex Camai, Ashley Suh, Bryan Han, Katherine Walker, Audrey Anderson, Lannawill Caruth, Anish Katta, Allison B. McCoy & Daniel W. Byrne. (2024) Identifying antinuclear antibody positive individuals at risk for developing systemic autoimmune disease: development and validation of a real-time risk model. Frontiers in Immunology 15.
Crossref
Crossref
Eleanor Frost, Jonathan N. Hofmann, Wen-Yi Huang, Christine G. Parks, Ashley A. Frazer-Abel, Kevin D. Deane & Sonja I. Berndt. (2023) Antinuclear Antibodies Are Associated with an Increased Risk of Diffuse Large B-Cell Lymphoma. Cancers 15:21, pages 5231.
Crossref
Crossref
S. Mejdoub, S. Feki, N. Farhat, M. Dammak, H. Hachicha, S. Sakka, A. Ayedi, F. Ayedi, C. Mhiri & H. Masmoudi. (2022) Antinuclear antibodies positivity is not rare during multiple sclerosis and is associated with relapsing status and IgG oligoclonal bands positivity. Revue Neurologique 178:8, pages 812-816.
Crossref
Crossref
Wilton Ferreira Silva Santos, Ana Paula de Castro Cantuária, Daniele de Castro Félix, Leandro Kegler Nardes & Igor Cabral Santos de Melo. (2022) The influence of demography and referral medical specialty on the detection of autoantibodies to HEP-2 cells in a large sample of patients. Advances in Rheumatology 62:1.
Crossref
Crossref
Bettina Santler & Jan Ehrchen. (2020) Antinukleäre AntikörperAntinuclear antibodies. Der Hautarzt 72:1, pages 71-80.
Crossref
Crossref
An Wang, Zhengyu Gu, Rongfeng Liao & Zongwen Shuai. (2019) Dry Eye Indexes Estimated by Keratograph 5M of Systemic Lupus Erythematosus Patients without Secondary Sjögren’s Syndrome Correlate with Lupus Activity. Journal of Ophthalmology 2019, pages 1-8.
Crossref
Crossref
. 2017. Uexküll, Psychosomatische Medizin. Uexküll, Psychosomatische Medizin
1
153
.
Alexander Chen, Hung-Ta Chen, Yih-Hsiou Hwang, Yi-Tsun Chen, Ching-Hsi Hsiao & Hung-Chi Chen. (2016) Severity of dry eye syndrome is related to anti-dsDNA autoantibody in systemic lupus erythematosus patients without secondary Sjogren syndrome. Medicine 95:28, pages e4218.
Crossref
Crossref
Ayşe Aynali, Buket Cicioğlu Arıdoğan, Salim Neşelioğlu & Özcan Erel. (2016) The comparison of antinuclear antibody positivity and thiol/disulfide levels / Antinükleer antikor pozitifliği ve tiyol/disülfid düzeylerinin karşılaştırılması. Turkish Journal of Biochemistry 41:1, pages 8-11.
Crossref
Crossref
Mark A. Sullivan, Tim Wentworth, James J. Kobie & Ignacio Sanz. (2012) Anti-idiotypic monobodies for immune response profiling. Methods 58:1, pages 62-68.
Crossref
Crossref
Kun-Yi Wang, Yao-Hsu Yang, Ya-Hui Chuang, Pei-Jung Chan, Hsin-Hui Yu, Jyh-Hong Lee, Li-Chieh Wang & Bor-Luen Chiang. (2011) The initial manifestations and final diagnosis of patients with high and low titers of antinuclear antibodies after 6 months of follow-up. Journal of Microbiology, Immunology and Infection 44:3, pages 222-228.
Crossref
Crossref
Henrique A. Mariz, Emília I. Sato, Silvia H. Barbosa, Silvia H. Rodrigues, Alessandra Dellavance & Luis E. C. Andrade. (2010) Pattern on the antinuclear antibody–HEp‐2 test is a critical parameter for discriminating antinuclear antibody–positive healthy individuals and patients with autoimmune rheumatic diseases. Arthritis & Rheumatism 63:1, pages 191-200.
Crossref
Crossref
S.M. Berney. (2009) Increased titres of anti-nuclear antibodies do not predict the development of associated disease in the absence of initial suggestive signs and symptoms. Yearbook of Medicine 2009, pages 30-31.
Crossref
Crossref